BioCryst制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Jon P Stonehouse | 3 | -411,673 |
Helen M. Thackray | 2 | -10,125 |
Michael L Jones | 2 | -9,045 |
Nancy J Hutson | 1 | -12,866 |
Yarlagadda S Babu | 1 | -31,515 |
Alane P Barnes | 1 | -4,175 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 0 | 0 |
最近12个月 | 0 | 16,866 | -16,866 |
最近18个月 | 0 | 495,199 | -495,199 |
BioCryst制药 内部交易
BioCryst制药 最新内部交易
Machelle Sanders | 董事 | 2023-06-15 | 卖出 | 4,000 | 25,611 |
$7.98
|
-44.99%
|
Nancy J Hutson | 董事 | 2023-06-14 | 卖出 | 12,866 | 81,818 |
$8.04
|
-45.40%
|
Helen M. Thackray | Chief R&D Officer | 2023-04-03 | 卖出 | 7,000 | 207,275 |
$8.29
|
-47.04%
|
Jon P Stonehouse | President & CEO | 2023-02-01 | 卖出 | 100,000 | 1,028,739 |
$10.38
|
-57.71%
|
Alane P Barnes | Chief Legal Officer | 2022-12-15 | 卖出 | 4,175 | 198,770 |
$10.88
|
-59.65%
|
Michael L Jones | Exec. Director, Finance - PAO | 2022-12-15 | 卖出 | 445 | 10,753 |
$10.9
|
-59.72%
|
Charles K Gayer | Chief Commercial Officer | 2022-12-15 | 卖出 | 6,100 | 211,610 |
$10.9
|
-59.72%
|
Jon P Stonehouse | President & CEO | 2022-12-15 | 卖出 | 14,100 | 897,730 |
$10.9
|
-59.72%
|
Anthony Doyle | CFO | 2022-12-15 | 卖出 | 5,700 | 163,966 |
$10.9
|
-59.72%
|
Helen M. Thackray | Chief R&D Officer | 2022-12-15 | 卖出 | 3,125 | 133,275 |
$10.89
|
-59.69%
|